Pharma Equity Group
0.08 DKK
+4.07 %
Less than 1K followers
PEG
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Dividend
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Pharma Equity Group
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Revenue | ||||||
| growth-% | ||||||
| EBITDA | -2.1 | -1.4 | -4.3 | -20.9 | -21.3 | -16.9 |
| EBIT | -2.1 | -1.4 | -4.3 | -20.9 | -21.3 | -17.2 |
| Profit before taxes | -32.9 | 5.4 | 3.5 | -26.8 | -26.2 | -26.4 |
| Net income | -32.9 | 5.4 | 3.5 | -24.6 | -24.4 | -25.4 |
| EPS | -1.06 | 0.10 | 0.10 | -0.02 | -0.02 | -0.02 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | 0.0 % | 0.0 % | -0.0 % | -0.0 % | -0.0 % |
Profitability and return on capital
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| EBITDA-% | ||||||
| EBIT-% | ||||||
| ROE | -95.9 % | 12.7 % | 7.6 % | -63.2 % | -50.0 % | -99.6 % |
| ROI | -57.1 % | 8.5 % | 4.9 % | -30.3 % | -37.2 % | -65.2 % |